Literature DB >> 21127066

Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells.

Dominique Thuringer1, Arlette Hammann, Naïma Benikhlef, Eric Fourmaux, André Bouchot, Guillaume Wettstein, Eric Solary, Carmen Garrido.   

Abstract

Extracellular heat shock protein HSP90α was reported to participate in tumor cell growth, invasion, and metastasis formation through poorly understood signaling pathways. Herein, we show that extracellular HSP90α favors cell migration of glioblastoma U87 cells. More specifically, externally applied HSP90α rapidly induced endocytosis of EGFR. This response was accompanied by a transient increase in cytosolic Ca(2+) appearing after 1-3 min of treatment. In the presence of EGF, U87 cells showed HSP90α-induced Ca(2+) oscillations, which were reduced by the ATP/ADPase, apyrase, and inhibited by the purinergic P(2) inhibitor, suramin, suggesting that ATP release is requested. Disruption of lipid rafts with methyl β-cyclodextrin impaired the Ca(2+) rise induced by extracellular HSP90α combined with EGF. Specific inhibition of TLR4 expression by blocking antibodies suppressed extracellular HSP90α-induced Ca(2+) signaling and the associated cell migration. HSPs are known to bind lipopolysaccharides (LPSs). Preincubating cells with Polymyxin B, a potent LPS inhibitor, partially abrogated the effects of HSP90α without affecting Ca(2+) oscillations observed with EGF. Extracellular HSP90α induced EGFR phosphorylation at Tyr-1068, and this event was prevented by both the protein kinase Cδ inhibitor, rottlerin, and the c-Src inhibitor, PP2. Altogether, our results suggest that extracellular HSP90α transactivates EGFR/ErbB1 through TLR4 and a PKCδ/c-Src pathway, which induces ATP release and cytosolic Ca(2+) increase and finally favors cell migration. This mechanism could account for the deleterious effects of HSPs on high grade glioma when released into the tumor cell microenvironment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127066      PMCID: PMC3030348          DOI: 10.1074/jbc.M110.154823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system.

Authors:  Katerina Sidera; Martina Samiotaki; Eleni Yfanti; George Panayotou; Evangelia Patsavoudi
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

2.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.

Authors:  A J Ekstrand; N Sugawa; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

4.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

5.  Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils.

Authors:  Frédéric Barabé; Guillaume Paré; Maria J G Fernandes; Sylvain G Bourgoin; Paul H Naccache
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

Review 6.  Angiogenesis as an immunopharmacologic target in inflammation and cancer.

Authors:  Xiu Wu Bian; Jian Hong Chen; Xue Feng Jiang; Jia Si Bai; Qing Liang Wang; Xia Zhang
Journal:  Int Immunopharmacol       Date:  2004-11       Impact factor: 4.932

7.  Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.

Authors:  Brenda K Eustace; Takashi Sakurai; Jean K Stewart; Dean Yimlamai; Christine Unger; Carol Zehetmeier; Blanca Lain; Claudia Torella; Stefan W Henning; Gerald Beste; Bradley T Scroggins; Len Neckers; Leodevico L Ilag; Daniel G Jay
Journal:  Nat Cell Biol       Date:  2004-05-16       Impact factor: 28.824

8.  Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.

Authors:  B Becker; G Multhoff; B Farkas; P-J Wild; M Landthaler; W Stolz; T Vogt
Journal:  Exp Dermatol       Date:  2004-01       Impact factor: 3.960

9.  Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains.

Authors:  Eun-Mi Hur; Yong-Soo Park; Byoung Dae Lee; Il Ho Jang; Hyeon Soo Kim; Tae-Don Kim; Pann-Ghill Suh; Sung Ho Ryu; Kyong-Tai Kim
Journal:  J Biol Chem       Date:  2003-11-20       Impact factor: 5.157

10.  Thimerosal causes calcium oscillations and sensitizes calcium-induced calcium release in unfertilized hamster eggs.

Authors:  K Swann
Journal:  FEBS Lett       Date:  1991-01-28       Impact factor: 4.124

View more
  40 in total

Review 1.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 2.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

3.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

Review 4.  Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?

Authors:  Dominique Thuringer; Carmen Garrido
Journal:  FASEB J       Date:  2019-07-26       Impact factor: 5.191

5.  Plasma immune analytes in patients with epithelial ovarian cancer.

Authors:  Matthew S Block; Matthew J Maurer; Krista Goergen; Kimberly R Kalli; Courtney L Erskine; Marshall D Behrens; Ann L Oberg; Keith L Knutson
Journal:  Cytokine       Date:  2015-03-03       Impact factor: 3.861

6.  Cell surface heparan sulfate proteoglycans are involved in the extracellular Hsp90-stimulated migration and invasion of cancer cells.

Authors:  Anastasiya V Snigireva; Veronika V Vrublevskaya; Yuri Y Skarga; Oleg S Morenkov
Journal:  Cell Stress Chaperones       Date:  2019-01-18       Impact factor: 3.667

7.  p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.

Authors:  Yiu To Yeung; Nicole S Bryce; Seray Adams; Nady Braidy; Mari Konayagi; Kerrie L McDonald; Charles Teo; Gilles J Guillemin; Thomas Grewal; Lenka Munoz
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

8.  Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury.

Authors:  Joshua A Smith; L Jay Stallons; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

Review 9.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

10.  TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.

Authors:  Hongliang Fang; Bing Ang; Xinyun Xu; Xiaohui Huang; Yanfeng Wu; Yanping Sun; Wenying Wang; Nan Li; Xuetao Cao; Tao Wan
Journal:  Cell Mol Immunol       Date:  2013-12-23       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.